Conference Chair Keynote Speakers
Dolores Di Vizio
Professor, Cedars Sinai Medical Center | 
Massimo Cristofanilli
Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Northwestern University | 
Shan Wang
Leland T. Edwards Professor in the School of Engineering, Stanford University | 
Sam Hanash
Director, McCombs Institute for Cancer Detection and Treatment, University of Texas MD Anderson Cancer Center | 
John Nolan
CEO, Cellarcus Biosciences, Inc. | 
Cheng-Ho Jimmy Lin
Chief Scientific Officer, Oncology, Natera |
|
Erkki Ruoslahti
Distinguished Professor and Former President, Sanford Burnham Prebys Medical Discovery Institute | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas | 
Jennifer Jones
NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute | 
Balaji Panchapakesan
Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI) | 
Yves A. DeClerck
Professor of Pediatrics and Biochemistry & Molecular Medicine, Children’s Hospital Los Angeles, University of Southern California | 
David Hoon
Professor, Director Department of Translational Molecular Medicine, John Wayne Cancer Institute |
OverviewSelectBIO Liquid Biopsies 2019 focuses primarily on
biofluid-based molecular biomarkers, such as circulating tumor DNA
(ctDNA) as well as circulating tumor cells (CTCs), and protein-based
circulating biomarkers. There is much interest in the potential of
ctDNA for developing biological fluid-based biopsies (such as using
plasma, urine, or other biofluids) and the presenters in this track
bring together the most up-to-date information and current
state-of-the-field. The conference further explores the potential of various minimally-invasive circulating
biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and
Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring and minimal residual disease detection. This conference is held concurrently with the Circulating Biomarkers 2019 Conference enabling delegates full access to the scientific presentations in both conferences, co-located exhibit hall, and extensive networking opportunities.
Information and Local Registration Facilities for this Conference are also available in: Japanese
|
 Korean
|
 Chinese (Simplified)
|
 Chinese (Traditional)
Agenda Topics- Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
- Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
- Emerging Technologies and Emerging Companies Showcase
- Technology Platforms for Interrogation
- Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
- Microfluidics Platforms for Diagnostics Development
- US vs. EU vs. Asia/Pacific Regulatory Landscape for Liquid Biopsies
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Confirmed Speakers to dateSergio Barberan-Soler, Director of Sequencing Technologies, Somagenics, Inc
Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
Hatim Husain, Assistant Professor of Medicine, University of California San Diego
Alexander Johnson-Buck, Research Assistant Professor, University of Michigan
Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC)
Alina Lelic, Marketing Manager, North America, Beckman Coulter
Jean-François Martini, Sr. Director, Translational Oncology, Immuno-Oncology, Early Development, Pfizer
Martin Schlumpberger, Associate Director, Scientific Applications, QIAGEN
Rachel Tam, Senior Scientific Researcher, Oncology Biomarker Development, Genentech
Kai Wang, Principal Scientist, Institute for Systems Biology
Kun Zhang, Professor, Department of Bioengineering, University of California San Diego
Kang Zhang, Founding Director, Institute for Genomic Medicine, University of California-San Diego
Jasmine Zhou, Professor, University of California-Los Angeles
Yazhen Zhu, Assistant Professor, David Geffen School of Medicine at UCLA
Bernhard Zimmermann, Vice President of Research and Development, Natera
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2019-03-27 00:00:002019-03-29 00:00:00Europe/LondonLiquid Biopsies 2019Liquid Biopsies 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com
Exosomes Technology Analysis Slide Deck 2018
